|
OGFRL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.00801614119928E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45940000084721E-08 |
| Normal-vs-Stage2 |
1.645070E-04 |
| Normal-vs-Stage3 |
2.598500E-03 |
| Normal-vs-Stage4 |
4.937500E-02 |
| Stage1-vs-Stage2 |
6.475600E-01 |
| Stage1-vs-Stage3 |
7.151600E-01 |
| Stage1-vs-Stage4 |
6.021600E-01 |
| Stage2-vs-Stage3 |
4.323600E-01 |
| Stage2-vs-Stage4 |
3.027400E-01 |
| Stage3-vs-Stage4 |
7.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.43980441089798E-11 |
| Normal-vs-AfricanAmerican |
3.455899999949E-06 |
| Normal-vs-Asian |
3.385800E-01 |
| Caucasian-vs-AfricanAmerican |
7.538200E-01 |
| Caucasian-vs-Asian |
3.725600E-01 |
| AfricanAmerican-vs-Asian |
3.587600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31039956663415E-10 |
| Normal-vs-Female |
2.51210000024038E-07 |
| Male-vs-Female |
2.090400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.976400E-03 |
| Normal-vs-Extreme_Weight |
4.77649999996999E-07 |
| Normal-vs-Obese |
7.03450000028027E-07 |
| Normal-vs-Extreme_Obese |
4.849500E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.372300E-02 |
| Normal_Weight-vs-Obese |
1.551550E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.678200E-01 |
| Extreme_Weight-vs-Obese |
2.771600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.219000E-01 |
| Obese-vs-Extreme_Obese |
3.524200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.829700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.22910032046764E-10 |
| Normal-vs-Age(61-80Yrs) |
5.18930000081852E-08 |
| Normal-vs-Age(81-100Yrs) |
2.030200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.450400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.115600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.515500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.371800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.566000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.220120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.78246306603569E-12 |
| Normal-VS-Type2 PRCC |
7.839000E-03 |
| Normal-VS-KIRP CIMP |
1.756290E-03 |
| Normal-VS-Unclassified PRCC |
4.41829999999754E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.52260000000548E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.710600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.932800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.807600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.599800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.612600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.401460E-03 |
| Normal-vs-N1 |
2.585900E-04 |
| Normal-vs-N2 |
9.645000E-01 |
| N0-vs-N1 |
1.157840E-01 |
| N0-vs-N2 |
2.983600E-01 |
| N1-vs-N2 |
9.293600E-02 |
|
|
